You are here: Industry Insights > Covaxin

News List

Covaxin trial participant’s death unrelated to ‘vaccine or placebo’: Bharat Biotech expresspharma
January 11, 2021
He was reported to be healthy in follow-up calls post seven days of his dosing and no adverse reaction was observed or reported, claims company.
Bharat Biotech to make 700 million doses in 2021 expresspharma
January 06, 2021
Dr Krishna Ella, Chairman and MD Bharat Biotech said that Covaxin trials '200 per cent honest'.
Concerns raised over India’s approval of COVID-19 vaccine with incomplete data europeanpharmaceuticalreview
January 05, 2021
The All India Drug Action Network has said it is “shocked” India has given approval to Covaxin, a COVID-19 vaccine with a lack of peer reviewed safety and efficacy data.
Drug activist group AIDAN raises concerns over EUA for COVAXIN expresspharma
January 05, 2021
The All India Drug Action Network (AIDAN), a drug activists group has issued a statement asking the DCGI to make public all the data and analyses on which the decisions have been made to grant EUA to the COVID-19 vaccines.
Brazilian Clinics plans deal with Bharat Biotech for five million doses of Covaxin expresspharma
January 05, 2021
A team from ABCVAC will travel to India for further discussions with Bharat Biotech, as per reports.
Mixed reactions from healthcare experts, activists over REU for Covaxin, Covishield expresspharma
January 05, 2021
Some ask for more transparency in the approval process and seek data related to vaccine trials while others say that grant of REU in clinical trial mode in an emergency situation is in public interest.
SEC recommends EUA for Covaxin from Bharat Biotech expresspharma
January 04, 2021
The expert panel deliberated on Bharat Biotech’s EUA application after it submitted additional data, facts and analysis after Friday's review meeting.
COVAXIN clinical trials recruit 23,000 subjects expresspharma
January 04, 2021
COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results.
DCGI approves Covishield and Covaxin for restricted emergency use in India expresspharma
January 04, 2021
DCGI’s decision comes after the Subject Expert Committee of CDSCO met on January 1-2, 2021 and recommended the grant of permission for restricted emergency use of these vaccines.
Vice President Venkaiah Naidu meets Bharat Biotech CMD, discusses status of Covaxin expresspharma
December 28, 2020
Naidu stressed the importance of PPPs in coming out with indigenous world-class products.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page